3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
15
Prostatic Neoplasms
13
Neoplasms
4
Breast Neoplasms
4
Vaginal Neoplasms
2
Uterine Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Endometrial Clear Cell Adenocarcinoma
2
Vulvar Neoplasms
1
Stage IA Uterine Sarcoma
1
Radiation Injuries
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Obesity
1
Neurotoxicity Syndromes
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Lung Neoplasms
1
Locally Advanced Cervical Cancer
1
Liver Neoplasms
1
Fatigue
1
Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation
1
Endometrial Adenocarcinoma
1
Desmoplastic Small Round Cell Tumor
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Breast Carcinoma In Situ
1
Biliary Tract Neoplasms
1
Interventions
pazopanib
5
Doxorubicin
3
Bevacizumab
3
carotuximab
2
Sorafenib
2
Radiotherapy, Conformal
2
Paclitaxel
2
Gemcitabine
2
tremelimumab
1
trebananib
1
temsirolimus
1
talimogene laherparepvec
1
romidepsin
1
regorafenib
1
indolepropanol phosphate
1
eribulin
1
durvalumab
1
cixutumumab
1
Watchful Waiting
1
Vascular Endothelial Growth Factor A
1
TTI-621
1
Sunitinib
1
Sirolimus
1
Razoxane
1
Observation
1
Magnetic Resonance Spectroscopy
1
Ifosfamide
1
HhAntag691
1
Fluorodeoxyglucose F18
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hemangiosarcoma
×
Brachytherapy
×
Clear all
No trials found.